Skip to content

Prevention of lymphedema by therapeutic elastic compression hoses; treatment efficacy.

The efficacy of therapeutic compression hoses for prevention of lymphedema after inguinal lymph node dissection in cancer patients – a randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22336
Enrollment
80
Registered
2007-03-27
Start date
2006-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inguinal lymph node dissection lymphedema lymfoedeem oppervlakkige liesklierdissectie therapeutisch elastische kousen compression hoses

Interventions

Therapeutic elastic compression hose for a period of 6 months, in addition to standard regimen of early ambulation and patient education.

Sponsors

The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (dpt of physiotherapy)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 18 years or older; 2. Inguinal lymphnode dissection because of metastases of melanoma or urogenital tumour.

Exclusion criteria

Exclusion criteria: 1. Deep venous thrombosis; 2. Manifest lymphedema or episodes of lymphedema in the past; 3. Isolated limb perfusion treatment; 4. Oedema as a result of venous insufficiency; 5. Psychiatric disorders; 6. Lacking basic proficiency in dutch.

Design outcomes

Primary

MeasureTime frame
Incidence of lymphedema (survival without lymphedema).

Secondary

MeasureTime frame
1. Early surgical complications (wound breakdown, lymphocele formation, wound infection); 2. Genital oedema; 3. Health related quality of life; 4. Body image; 5. Ccompliance to usage of the hose; 6. Use of professional homecare; 7. Lymphedema requiring treatment.

Contacts

Public ContactM.M. Stuiver

The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Dpt of Physiotherapy

m.stuiver@nki.nl+31 20-5122586

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)